Rockwell Medical Inc (RMTI) - Total Assets
Based on the latest financial reports, Rockwell Medical Inc (RMTI) holds total assets worth $57.49 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See RMTI book value for net asset value and shareholders' equity analysis.
Rockwell Medical Inc - Total Assets Trend (1997–2024)
This chart illustrates how Rockwell Medical Inc's total assets have evolved over time, based on quarterly financial data.
Rockwell Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Rockwell Medical Inc's total assets of $57.49 Million consist of 62.5% current assets and 37.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.5% |
| Accounts Receivable | $8.29 Million | 14.0% |
| Inventory | $5.78 Million | 9.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $10.21 Million | 17.2% |
| Goodwill | $921.00K | 1.6% |
Asset Composition Trend (1997–2024)
This chart illustrates how Rockwell Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see RMTI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rockwell Medical Inc's current assets represent 62.5% of total assets in 2024, an increase from 25.0% in 1997.
- Cash Position: Cash and equivalents constituted 26.5% of total assets in 2024, up from 2.8% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is intangible assets at 17.2% of total assets.
Rockwell Medical Inc Competitors by Total Assets
Key competitors of Rockwell Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Rockwell Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.92 | 2.41 | 5.43 |
| Quick Ratio | 3.50 | 2.00 | 5.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $27.93 Million | $20.04 Million | $56.68 Million |
Rockwell Medical Inc - Advanced Valuation Insights
This section examines the relationship between Rockwell Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.59 |
| Asset Growth Rate (YoY) | 13.5% |
| Total Assets | $59.21 Million |
| Market Capitalization | $35.00 Million USD |
Valuation Analysis
Below Book Valuation: The market values Rockwell Medical Inc's assets below their book value (0.59x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Rockwell Medical Inc's assets grew by 13.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Rockwell Medical Inc (1997–2024)
The table below shows the annual total assets of Rockwell Medical Inc from 1997 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $59.21 Million | +13.48% |
| 2023-12-31 | $52.17 Million | +11.88% |
| 2022-12-31 | $46.63 Million | -3.99% |
| 2021-12-31 | $48.57 Million | -37.52% |
| 2020-12-31 | $77.75 Million | +75.44% |
| 2019-12-31 | $44.32 Million | -15.68% |
| 2018-12-31 | $52.56 Million | -10.59% |
| 2017-12-31 | $58.78 Million | -29.31% |
| 2016-12-31 | $83.15 Million | -5.32% |
| 2015-12-31 | $87.82 Million | -10.39% |
| 2014-12-31 | $98.00 Million | +169.51% |
| 2013-12-31 | $36.36 Million | +113.58% |
| 2012-12-31 | $17.03 Million | -46.70% |
| 2011-12-31 | $31.94 Million | -13.60% |
| 2010-12-31 | $36.97 Million | +5.99% |
| 2009-12-31 | $34.88 Million | +83.96% |
| 2008-12-31 | $18.96 Million | -16.85% |
| 2007-12-31 | $22.80 Million | +73.37% |
| 2006-12-31 | $13.15 Million | +42.03% |
| 2005-12-31 | $9.26 Million | +20.26% |
| 2004-12-31 | $7.70 Million | +9.31% |
| 2003-12-31 | $7.04 Million | +9.16% |
| 2002-12-31 | $6.45 Million | +6.53% |
| 2001-12-31 | $6.06 Million | +49.51% |
| 2000-12-31 | $4.05 Million | -9.96% |
| 1999-12-31 | $4.50 Million | -15.09% |
| 1998-12-31 | $5.30 Million | +47.22% |
| 1997-12-31 | $3.60 Million | -- |
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterily… Read more